Just Released: "Portugal Pharmaceuticals & Healthcare Report Q2 2014"
While Portugal's economy is expected to register growth in FY14, we expect that IMF-imposed austerity measures and household deleveraging will continue to be a drag on consumer spending. The healthcare budget will continue to be slashed in 2014; the authorities have to make further cuts in reimbursement; and reference prices are continually pushed downwards. The few opportunities for growth are being taken by manufactures of generic drugs - which are gaining market share - and some nonprescription medicines. New regulations...
View full press release